Pharmacokinetics and metabolism studies on (3-tert-butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy) pyrazolo[1,5-d][1,2,4]triazine, a functionally selective GABA(A) alpha5 inverse agonist for cognitive dysfunction.

(3-tert-Butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy)pyrazolo[1,5-d][1,2,4]triazine (1) was recently identified as a functionally selective, inverse agonist at the benzodiazepine site of GABA(A) alpha5 receptors and enhances performance in animal models of cognition. The routes of metabolism of this compound in vivo in rat have been well characterised, the identities of the major metabolites are confirmed by synthesis and their biological profiles were evaluated. An unusual oxidation of the pyrazolo[1,5-d][1,2,4]triazine core to the corresponding pyrazolo[1,5-d][1,2,4]triazin-4(5H)-one scaffold by aldehyde oxidase has been observed.

[1]  G. W. Johnson,et al.  Synthesis of 3,6-dichloro-4-(2-chloro-1,1-dimethylethyl)pyridazine , 1988 .

[2]  E A Barnard,et al.  International Union of Pharmacology. XV. Subtypes of gamma-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function. , 1998, Pharmacological reviews.

[3]  R. Skelton,et al.  Benzodiazepine receptor antagonists flumazenil and CGS 8216 and inverse-agonist β-CCM nhance spatial learning in the rat: Dissociation from anxiogenic actions , 1993, Psychobiology.

[4]  P. Whiting,et al.  Cloning of cDNA sequences encoding human alpha 2 and alpha 3 gamma-aminobutyric acidA receptor subunits and characterization of the benzodiazepine pharmacology of recombinant alpha 1-, alpha 2-, alpha 3-, and alpha 5-containing human gamma-aminobutyric acidA receptors. , 1993, Molecular pharmacology.

[5]  R. Mckernan,et al.  theta, a novel gamma-aminobutyric acid type A receptor subunit. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[6]  R. Mckernan,et al.  Which GABAA-receptor subtypes really occur in the brain? , 1996, Trends in Neurosciences.

[7]  R. Horowski,et al.  SEVERE ANXIETY INDUCED BY FG 7142, A β-CARBOLINE LIGAND FOR BENZODIAZEPINE RECEPTORS , 1983, The Lancet.

[8]  G. Dawson,et al.  An orally bioavailable, functionally selective inverse agonist at the benzodiazepine site of GABAA alpha5 receptors with cognition enhancing properties. , 2004, Journal of medicinal chemistry.

[9]  M. Rashidi,et al.  Quantitative study of the structural requirements of phthalazine/quinazoline derivatives for interaction with human liver aldehyde oxidase. , 2001, Chemical & pharmaceutical bulletin.

[10]  J. Lancelot,et al.  Pyrazolo[1,5-d]triazines-1,2,4. I. Dérivés pyrazoliques , 1980 .

[11]  P. Whiting,et al.  The pharmacology of recombinant GABAA receptors containing bovine α1, β1, γ2L sub‐units stably transfected into mouse fibroblast L‐cells , 1992 .

[12]  B. Långström,et al.  A 11C-methyl stannane (5-[11C]methyl-1-aza-5-stannabicyclo[3.3.3]undecane) for use in palladium-mediated [11C]C-C bond forming reactions with organohalides , 2004 .

[13]  Kuangsen Sung,et al.  Synthesis of [(4,5‐disubstituted‐4H‐1,2,4‐triazol‐3‐yl)thio]alkanoic acids and their analogues as possible antiinflammatory agents , 1992 .

[14]  D. Nutt,et al.  Acute and chronic effects of the benzodiazepine receptor ligand FG 7142: proconvulsant properties and kindling , 1984, British journal of pharmacology.

[15]  E. Petersen.  DMCM: a potent convulsive benzodiazepine receptor ligand. , 1983, European journal of pharmacology.